Epidemiological Aspects of Rhinitis and Asthma: Comorbidity or United Airway Disease by Vujnovic, Sanela Domuz & Domuz, Adrijana
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 2
Epidemiological Aspects of Rhinitis and Asthma:
Comorbidity or United Airway Disease
Sanela Domuz Vujnovic and Adrijana Domuz
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.76773
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
l     j i   rij  
dditional infor ation is available at the end of the chapter
Abstract
Bearing in mind the results of the epidemiological studies, the logical question arises 
whether allergic rhinitis represents an earlier clinical manifestation of allergic airway dis-
ease or itself is causative for asthma. Comorbidity or one disease, the diagnosis of aller-
gic rhinitis often precedes the development of asthma. Literature reports that 40–90% of 
asthmatics have symptoms of allergic rhinitis. The epidemiological evidence also sug-
gests that allergic rhinitis and asthma radially presented one united airway disease with 
two-stage than two separate diseases. Symptoms of one disease often predominate and 
are unrecognized or hidden of another disease even if they exist. The epidemiology evi-
dence of comorbidity of allergic rhinitis and asthma confirmed the new concept of the 
united airway diseases. Despite the evidence of the correlation between allergic rhinitis 
and asthma, there is some resistance in clinical practice in recognizing this link.
Keywords: asthma, allergic rhinitis, united airway disease, epidemiology, prevalence, 
comorbidity, respiratory symptoms
1. Introduction
We have to agree with Togias [1] that the respiratory system has been one of the victims of 
fragmented medical knowledge. The respiratory system is most often viewed as two separate 
systems, upper and lower. These have resulted in lost opportunities to fully understand the 
function of the respiratory system [1]. Upper and lower respiratory systems have similarities 
in histology, physiology, and pathophysiology [2]. The nose warms, filters, and humidifies 
inhaled air. Impaired air warming and humidification by the nose may cause bronchocon-
striction. A reduced function of the nose can be caused by congestion forces the patient to 
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mouth breathing. Also, there are similarities in inflammation response between allergic rhi-
nitis and asthma [3, 4]. Allergic rhinitis and asthma are frequently associated with sensitiza-
tion to similar airborne allergens [5]. Some authors suggest the existence of a nasal-bronchial 
reflex as a cause of bronchial reactivity in a patient with nasal inflammation [6, 7]. That’s why 
recent studies suggest new theory or concept that these two diseases should be viewed as 
united diseases (Figure 1) [8, 9]. The epidemiology evidence of comorbidity of allergic rhinitis 
and asthma confirmed the new concept of the united airway diseases.
Comorbidity of allergic rhinitis in asthmatics results in frequent emergency visits, asthma 
exacerbation, asthma-related hospitalizations, and higher asthma-related medical costs [4]. 
Despite the evidence of the correlation between allergic rhinitis and asthma, there is some 
resistance in clinical practice in recognizing this link [10]. Also, the guidelines for the treat-
ment of allergic rhinitis and asthma are inconsistently implemented. The consequences of this 
are a very large number of patients with inadequate diagnosis, no treatment, and poor control 
of the disease [11, 12].
Most of the epidemiological studies investigate only one allergic disease, asthma or rhinitis. 
In these studies, another allergic disease was not observed as a comorbidity or a confounding 
factor. Studies that consider asthma and rhinitis as comorbidity are scarce, but the results of 
available studies showed that these two diseases are in a high percentage in comorbidity. The 
percentage of comorbidity showed continuity through different ages of the respondents. A 
high percentage (70–90%) of rhinitis symptoms in asthmatics was presented in children and 
the elderly population [13–15].
Despite its high comorbidity, there are surprisingly scarce studies about the treatment of AR 
in children with asthma or vice versa [14, 15]. Children with allergic rhinitis comorbidity were 
more likely to have incomplete asthma control in Groot et al. study [15].
2. Epidemiological evidence for the link between allergic rhinitis 
and asthma
The World Health Organization (WHO) through the Allergic Rhinitis and its Impact on 
Asthma (ARIA) program tried to understand the possible links between allergic rhinitis and 
asthma [16]. According to the ARIA study, patients with severe persistent rhinitis more likely 
Figure 1. Possible link between asthma and allergic rhinitis.
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have comorbidity with asthma [16]. Epidemiological evidence also suggests coexistence of 
asthma and allergic rhinitis in the same patients [17]. Symptoms of one disease often predom-
inate and are unrecognized or hidden of another disease even they exist [2]. The epidemio-
logical evidence also suggests that it is radially one disease with two stages than two separate 
diseases. Underdiagnosis of allergic rhinitis in asthmatics patients is common. Comorbid 
allergic rhinitis has a clinically relevant effect on asthma, especially on hospitalization and 
emergency visits [12]. Treating allergic rhinitis in these patients decreased asthma-related 
medication utilization [17]. Patients with allergic rhinitis also can be underdiagnosed with 
asthma [12].
2.1. Prevalence of allergic rhinitis and asthma
The prevalence of allergic rhinitis and asthma has increased worldwide over recent decades 
[13, 18].
Studies appear to indicate that the changes in the prevalence of allergic rhinitis and asthma 
differ, but they were not designed to show the variation of the link between these two diseases 
[16]. Epidemiological studies have no standard set of diagnostic criteria for allergic rhinitis or 
asthma, so it is very difficult to compare the results. Most of the studies used a questionnaire 
to define a prevalence, or they are self-reported-based study.
2.1.1. Asthma
A number of epidemiologic studies have reported striking differences in asthma prevalence. 
The largest multicentric study on asthma prevalence in children the International Study of 
Asthma and Allergies in Children (ISAAC) showed the asthma prevalence increment trend in 
children in the period from 1994 to 1999 [19]. The lowest asthma prevalence symptoms values 
in children aged 6–7 years were in the Indian subcontinent, while the highest asthma preva-
lence symptoms were in Latin America, North America, and Oceania [19, 20]. For the older 
age group (13–14 years), the lowest prevalence was in the region of Asia and Pacific, Eastern 
Mediterranean, and the Indian subcontinent, while children from North America had the 
highest frequency of asthma symptoms [19, 20]. Wheezing prevalence in the last 12 months 
also had a similar movement trend, with the lowest prevalence in North and Eastern Europe 
(5%) and the highest in the region of Latin America and Oceania (>20%) [19]. However, a dif-
ferent trend pattern of severe asthma symptom prevalence movement was noticed. Africa, the 
Indian subcontinent and Eastern Mediterranean had the highest asthma prevalence character-
ized with a severe form of asthma in children, while children in Latin America had the low-
est prevalence of severe asthma symptoms [19]. Twenty-one centers that participated in the 
multicentric study had the asthma prevalence in children larger than 20%, while seventeen 
centers had the prevalence lower than 5% [19, 21].
Generally, the prevalence of asthma in children showed the northwest-southeast gradient 
movement [22]. This kind of trend is especially expressed in eastern continent. The results of 
ISAAC study show the highest asthma prevalence in English-speaking countries and Latin 
America and the higher prevalence in West compared to East Europe and the lowest in Asia 
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and Africa regions [19]. The Great Britain has the highest asthma prevalence in children (32%), 
then Bulgaria, Czech Republic, Ireland, and Norway. The prevalence in Albania and Greek 
was the lowest (<5%) [19, 21].
Prevalence of asthma among the elderly population was 10.9% in the study by Pite et al. [13]. 
The prevalence of asthma increased with the number of rhinitis symptoms, from 2.1% in no 
rhinitis symptoms group to 44.4% in nasal symptoms plus ocular symptoms group [13].
2.1.2. Allergic rhinitis
Allergic rhinitis has increased in prevalence during last decades with the highest prevalence 
among children and adolescents [7, 23–25].
The prevalence of rhinitis among the 6- to 7-year-old children was 6.4% in Eastern and 
Northern Europe and 7.3% in Western Europe [26]. Higher prevalence of rhinitis symptom 
was among older children (13–14 years old) where 10.5% children in Eastern and Northern 
Europe and 14.5% in Western Europe have rhinitis symptoms. Children from Georgia had 
the lowest prevalence (2.8%), while children from Polish (18.9%) and Isle of Man (20.2%) had 
the highest prevalence of rhinitis [26]. It was found that countries with a low prevalence of 
asthma also had a low prevalence of rhinitis [26]. In addition to the European continent, the 
highest prevalence of rhinitis was observed in younger children in Latin America (12%) and 
older children on the African continent (21.7%). The lowest prevalence of rhinitis in the 6- to 
7-year-old children was in Africa (3.6%) and the Indian Subcontinent (3.9%) while in older 
children in the Indian Subcontinent (10%) [26].
The recent studies suggest a higher prevalence of rhinitis among the middle-aged population 
(20–28%) [23, 25, 27]. Pite et al. study showed that rhinitis was a highly prevalent but under-
diagnosed and undertreated disease in the elderly population [13]. About 80% of patients had 
rhinitis symptoms, but only half of them had a diagnosis and/or treatment [13].
2.2. Comorbidity of allergic rhinitis and asthma
Epidemiological studies show significant comorbidity of these two diseases. Literature reports 
that 40–90% of asthmatics have symptoms of allergic rhinitis, while patients with allergic rhi-
nitis have significantly less prevalence of asthma symptoms (10–40%) (Figure 2) [16, 28].
However, it should be emphasized that the prevalence of allergic rhinitis in asthmatics is sig-
nificantly higher than in the general population (10–20%). Conversely, there is a significantly 
higher prevalence of asthma symptoms among patients with allergic rhinitis than the general 
population (an average of 5–15%). The association between allergic rhinitis and asthma had 
been examined in several studies. The strength of the association with asthma increased with 
increased persistence and severity of rhinitis [13]. The prevalence of asthma increased with 
the number of rhinitis symptoms, from 2.1% in no rhinitis symptoms group to 44.4% in nasal 
symptoms plus ocular symptoms group [13]. A French study showed that 58% of asthmatics 
children had symptoms of allergic rhinitis [30]; the Italian study showed even higher percent-
age (70%) [29]. Prevalence of allergic rhinitis in patients with classic asthma was 50–69% in the 
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study by Tajiri et al. [4]. Among patients with physician-diagnosed asthma, 64% had allergic 
rhinitis in the study by Eriksson et al. [31]. Symptoms of allergic rhinitis were more common 
if asthma symptoms were more severe [30, 32]. Children with exercise-induced asthma have 
a significantly higher prevalence of allergic rhinitis symptoms [32]. The epidemiological evi-
dence consistently demonstrates the coexistence of allergic rhinitis and asthma [17].
The majority of asthmatic patients have seasonal or persistent allergic rhinitis [17, 33]. Also, the 
presence of allergic rhinitis in asthmatics has been confirmed as a marker of asthma severity 
[32, 33]. A higher prevalence of allergic rhinitis was observed among children who reported at 
least four wheezing episodes in the last year or sleep disorders due to acute episodes [32, 34]. 
Consequently, better asthma control can be achieved if the diagnosis and treatment of allergic 
rhinitis are adequately done [15]. Comorbidity of allergic rhinitis and other variant forms 
of asthma (cough variant, exercise-induced) has also been observed in epidemiological stud-
ies [4, 32]. Many patients with allergic rhinitis do not have symptoms of classical asthma, 
but they present with airway hyperresponsiveness and subclinical inflammation of the lower 
respiratory airway [35]. The results of previous studies showed that almost 50% of patients 
with bronchial hyperreactivity reported no respiratory symptoms [36]. These patients usually 
develop asthma but remain underdiagnosed with asthma [12, 28]. Also, allergic rhinitis is not 
appropriate recognition in patients with asthma [28, 37]. Many patients with allergic rhinitis 
self-manage the symptoms or do not recognize allergic rhinitis as a condition needing treat-
ment or physicians help [12]. The Portuguese study showed that more than half of patients 
with rhinitis symptoms had no diagnosis by a physician [13]. This shows that these patients 
are untreated for allergic rhinitis. It is important to emphasize that patients with mild forms 
of allergic rhinitis or asthma remain in high percentage without diagnosis and adequate treat-
ment [32]. Esteban et al. found in their study that 53% asthmatics children were underdiag-
nosed with allergic rhinitis, and asthma was not well controlled in 77% of these children. Only 
33% of the children with allergic rhinitis diagnosis were receiving a treatment by ARIA recom-
mendations. Children with poorly controlled allergic rhinitis had poorer asthma control [11].
Figure 2. Prevalence and comorbidity of allergic rhinitis and asthma.
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Untreated allergic rhinitis in asthmatics contributed to severity symptoms, exacerbation, and 
uncontrolled asthma [16, 28]. The authors reported that treatment of allergic rhinitis was asso-
ciated with reduced risk of emergency visits and hospitalization for asthma [3].
3. Allergic rhinitis as risk factor for asthma
Bearing in mind the results of the epidemiological studies, the logical question arises whether 
allergic rhinitis represents an earlier clinical manifestation of allergic airway disease or itself 
is causative for asthma [16, 17]. Comorbidity or one disease, the diagnosis of allergic rhinitis 
often precedes the development of asthma [4, 12]. Studies undoubtedly suggest that allergic 
rhinitis is a risk factor for asthma [4]. A pathophysiological mechanism which can explain the 
increased risk of developing asthma in patients with allergic rhinitis is airway hyperrespon-
siveness. Even 40% of patients with allergic rhinitis showed hyperreactivity to methacholine 
challenge. Such patients are at greater risk to develop asthma during the next 4–5 years [12]. 
Also, allergic rhinitis during childhood was associated with increased risk of asthma devel-
opment in preadolescence and adolescence [28]. The Children’s Respiratory Study showed 
that allergic rhinitis in the first year of life was associated with a risk of developing asthma by 
6 years of age [38]. The study by Settipane et al. showed that significantly more (10.5%) of the 
students diagnosed with allergic rhinitis went on the develop asthma compared with those 
who did not have allergic rhinitis (3.6%) [39]. The presence of bronchial hyperresponsiveness 
increased the risk for severe symptoms of allergic rhinitis and asthma and earlier develop-
ment of asthma in children with allergic rhinitis [12]. It is important to recognize bronchial 
hyperresponsiveness as a marker of prognostic significance [17]. Epidemiological studies sug-
gest that patients with bronchial hyperresponsiveness without symptoms of classic asthma 
are more often underdiagnosed with asthma [28].
4. Atopic march
The concept of the atopic march was developed to describe the progression of atopic disor-
ders from atopic dermatitis (AD) in infants to allergic rhinitis and asthma in children [40, 41]. 
The theory of atopic march implies that young children with atopic dermatitis or food allergy 
may develop airway allergy such as asthma or allergic rhinitis later in life [40, 42].
The concept of atopic march has been supported by cross-sectional and longitudinal studies 
[40, 42]. Atopic dermatitis as the first step in the development of atopic march occurs in 45% 
of children in the first 6 months of life and during the first year of life in 60% of children. In 
children with atopic dermatitis in the first 2 years of life, an average of 50% of these children 
develops asthma during subsequent years [42]. The occurrence of only one allergic manifesta-
tion, such as recurrent wheeze, eczema, or food allergy, during infancy, was associated with 
a good prognosis, where over 70% were symptom-free at 8 years of age. Among the children 
with two or more of any allergic manifestations in infancy, more than half had any allergic 
disease at 8 years of age [43]. In addition, comorbidity increased from infancy to 8 years of age 
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as a consequence of the increasing prevalence of asthma and allergic rhinitis. Furthermore, 
the more allergic manifestations a child had in infancy, the greater the risk of allergic disease 
and comorbidity at 8 years of age [43]. In late adulthood, allergic symptoms generally become 
less frequent and tend to disappear, but in some, new-onset allergy or asthma may develop in 
old age [44]. Results of studies showed that the mean age at onset of atopic comorbidities was 
1.8 ± 1.0 years for food allergy, 2.2 ± 1.1 years for asthma, 2.3 ± 1.3 years for allergic conjuncti-
vitis, and 2.4 ± 1.3 years for allergic rhinitis [45]. A systematic review of the literature by van 
der Hulst et al. showed that there is an increased risk of developing asthma by 6 years among 
children with eczema [46]. The pooled OR for the risk of asthma after eczema, compared 
with children without eczema, in birth cohort studies was 2.14. In eczema cohort studies, the 
prevalence of asthma by the age of 6 years was 29.5%. The proportion of children with eczema 
developing asthma is clearly higher than among those without eczema, and the “rates” for 
asthma are three- to fourfold higher than in the general population [46]. However, asthma 
develops in only approximately one in every three children with eczema. Kapoor et al. exam-
ined the prevalence of allergic rhinitis and asthma in 2270 children with physician-confirmed 
AD and found that by 3 years of age, nearly 66% of the subjects reported to have allergic rhi-
nitis, asthma, or both, and the presence of these diseases correlated with poor AD control [47]. 
These results should be interpreted with caution because of the heterogeneity of the cohorts.
The Tasmanian Longitudinal Health Study investigated the influence of eczema on the devel-
opment of asthma from childhood to adult life and found that childhood eczema was signifi-
cantly associated with new-onset asthma in three separate life stages: preadolescence (hazard 
ratio 1.70; 95% confidence interval 1.05–2.75), adolescence (2.14; 1.33–3.46), and adult life 
(1.63; 1.28–2.09) [48]. Results from another two cohorts studies, the Melbourne Atopic Cohort 
Study (MACS) and the LISAplus study, showed that food sensitization in the first 2 years of 
life increased the risk of subsequent asthma and allergic rhinitis (MACS OR = 8.3 for asthma 
and aOR = 3.9 for allergic rhinitis; LISAplus OR = 14.4 for asthma and OR = 7.6 for allergic 
rhinitis) [49].
The risk of developing atopic diseases is complex, and the temporal pattern described in the 
atopic march may not be a simple progression [40, 43]. Studies found that many individual 
children do not follow the classical allergic march [49, 50]. For this reason, different patterns 
of allergic morbidity and the coexistence of the different manifestations, rather than progres-
sive development of one underlying disease, have been suggested [43]. Several studies have 
suggested that, even though they are associated, the different combinations of allergic mani-
festations seen over time suggest the coexistence rather than the progressive development of 
the same underlying disease [43]. Children with early eczema who develop asthma and aller-
gic rhinitis might represent one specific phenotype of eczema, characterized by eczema plus 
either wheezing or a specific pattern of sensitization [43]. The results of MAS Study showed 
that children with eczema and without early wheeze were not at increased risk for the devel-
opment of asthma. These results implied that eczema alone may not be the first most predic-
tive phenotype in the atopic march [51]. Eczema before 2 years of age without the cofactor of 
wheeze before the age of 3 years and without a specific pattern of atopic sensitization was not 
associated with an increased risk of wheezing at 7 years of age (adjusted OR 1.11). In addition, 
the authors suggest that the combination of eczema with early wheeze is a distinct phenotype 
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rather than a representation of a progressive pattern of atopic diseases [51]. However, the risk 
for development of asthma at 7 years of age among children with early eczema and atopic sen-
sitization to less common antigens but without concomitant wheeze was stronger (adjusted 
OR, 6.68) than the association between early eczema with early wheezing (adjusted OR, 2.84). 
This is in consistent with the pattern of the atopic march in which eczema with atopic sen-
sitization presents a higher risk for the development of atopic respiratory disease [52]. 
The cohort of children with an early-onset AD with a lower rate of sensitization to allergens 
was associated with a low risk for developing asthma. The cohort of children with multiple 
sensitizations and with familiar history of asthma had a higher prevalence of asthma than 
the general population in the study of Amat et al. [53]. Also, studies showed that patients 
with eczema with specific IgE antibodies to common environmental allergens present by 2 
to 4 years of age are at higher risk for progressing in the atopic march to allergic rhinitis and 
asthma than those with eczema without IgE sensitization [53, 54]. Current evidence suggests 
that further refining early childhood eczema phenotypes may represent a more robust mea-
sure of the first phenotype of the atopic march, with a greater predictive value of identifying 
those at risk of developing allergic rhinitis and asthma [52].
Likewise, many studies in animal models demonstrate that epidermal barrier dysfunction can 
be caused by repeated sensitization to allergens to the skin, which leads to phenotypes of AD 
systemic sensitization and increased risk of allergic rhinitis lung inflammation and airway 
hyperresponsiveness [43]. A study in a mouse model showed that epicutaneous aeroallergen 
exposure induces systemic Th2 immunity that predisposes to allergic nasal responses, sug-
gesting that the skin is a potent site for antigen sensitization in the development of experimen-
tal allergic rhinitis [43]. Experimental studies showed that epicutaneous sensitization with 
ovalbumin induced AD and airway hyperresponsiveness to methacholine after challenge 
with aerosolized ovalbumin [43].
The pathophysiological mechanism of atopic march has been unknown. Skin barrier dys-
functions can explain partly the mechanism of atopic march [50]. Namely, skin barrier defect 
can promote entry for allergens [50]. Epicutaneous sensitization to aeroallergens has been 
thought to be responsible, with subsequent migration of sensitized T cell into the nose and 
airways, for development of allergic upper and lower airway diseases [55]. Sensitization that 
followed eczema is likely to be a step in the pathophysiological pathway between eczema and 
asthma [56]. Previous data support the hypothesis that respiratory allergies are secondary to 
allergic sensitization that occurs after epidermal skin barrier defect [50].
4.1. Conclusion
The atopic march is a useful paradigm to describe the clinically observed progression of atopic 
diseases in certain children [52]. Whether each step in the march is necessary for progression to 
the next or further defining of these phenotypes would be more useful in identifying children 
at risk for developing chronic allergic diseases is still a matter of debate. Allergic manifesta-
tions can develop at any point in life. Many children will experience only one or perhaps two 
atopic manifestations, and the development of these can be interspaced by several years [57]. 
The progression of allergic disease is not uniform in all atopic children. However, the 
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 coexistence of allergic manifestations in the same child has been shown to be more common than 
expected by chance alone [43]. Also, it is still unclear why some infants with AD outgrow the 
disease with increasing age, whereas others will march to develop other allergic diseases [41]. 
Therefore, it is not uncommon that an adult with “new-onset” asthma are unable to remember 
whether they had allergic diseases in childhood [57]. A better understanding of what places a 
subset of children with eczema or allergic rhinitis into the risk group for developing asthma is 
critically important. “Given that most infants with eczema or early wheezing do not develop 
rhinitis and asthma, further refinement of these early phenotypes or additional risk factors is 
important for them to be useful” [52]. It is important to define more precise phenotypes of the 
early stages of the atopic march that may improve its utility in predicting the development of 
later atopic diseases [52].
Although it has become evident that the mechanisms by which allergen exposure occurs 
through impaired skin barriers can initiate systemic allergy and predispose individuals to AD, 
allergic rhinitis, and asthma, the mechanisms of the atopic march are still largely unknown [41]. 
The findings of studies support the atopic march theory on a population level. But the con-
cept of atopic march is not the strongest factor at the individual level of children with allergic 
disease [43].
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